Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 69, No. 2, 2008   

Free Abstract     Article (Fulltext)     Article (PDF 197 KB)     
Free Access

Mini Review

Endocrine Late Effects of Childhood Cancer Therapy: A Report from the Children's Oncology Group
Radha Nandagopala, Caroline Laverdièreb, Daniel Mulrooneyc, Melissa M. Hudsond, Lillian Meachama

aDivision of Pediatric Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga., USA;
bService of Hematology/Oncology, Sainte-Justine Hospital, University of Montreal, Montreal, Que., Canada;
cDivision of Pediatric Hematology/Oncology/Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minnesota, Minn., and
dDepartment of Hematology-Oncology, St. Jude Children's Research Hospital and the University of Tennessee College of Medicine, Memphis, Tenn., USA

Address of Corresponding Author

Horm Res 2008;69:65-74 (DOI: 10.1159/000111809)


 goto top of page Key Words

  • Endocrine late effects
  • Childhood cancer
  • Chemotherapy
  • Radiation therapy
  • Pediatrics

 goto top of page Abstract

Pediatric oncologists are curing increasing numbers of patients with childhood cancer, and most children diagnosed with a malignancy may now be expected to become long-term survivors. As the number of childhood cancer survivors grows, so too does the need for evidence-based surveillance of the long-term effects of cancer therapy. Long-term effects involving the endocrine system represent a frequent complication of therapy. The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers(COG LTFUG), most recently updated in 2006, provide a summary of the known endocrine late effects of surgery, radiation, chemotherapy, and stem cell transplant. This paper summarizes the scope and nature of the endocrine late effects of childhood cancer therapy based upon a review of the pertinent medical literature, and demonstrates how pediatric oncologists can use these guidelines in clinical practice.

Copyright © 2007 S. Karger AG, Basel


 goto top of page Author Contacts

Radha Nandagopal, MD
c/o Children's Oncology Group, Publications Office
440 E. Huntington Drive, 4th Floor
Arcadia, CA 91006 (USA)
Tel. +1 626 241 1509, Fax +1 626 445 4334, E-Mail rnandagopal@hotmail.com


 goto top of page Article Information

Received: December 12, 2006
Accepted after revision: July 31, 2007
Published online: December 5, 2007
Number of Print Pages : 10
Number of Figures : 0, Number of Tables : 4, Number of References : 46

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 18059086)
Download Citation



This journal is part of the third subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel